Clinical trial
Prospective, Non-randomized, Open-label, Mono-centric, Cohort Study on the Absorption of Oral Rivaroxaban in Patients With a Cervical Spinal Cord Injury
NCT02970773 is registered in ClinicalTrials.gov with Swiss Paraplegic Research, Nottwil as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Non-randomized, Open-label, Mono-centric, Cohort Study on the Absorption of Oral Rivaroxaban in Patients With a Cervical Spinal Cord Injury
- Lead sponsor
- Swiss Paraplegic Research, Nottwil
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- December 4, 2017
- Completion date
- December 7, 2018
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.